OPKO Health EBITDA 2010-2024 | OPK

OPKO Health ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
OPKO Health Annual EBITDA
(Millions of US $)
2023 $-51
2022 $-116
2021 $98
2020 $144
2019 $-179
2018 $-74
2017 $-174
2016 $0
2015 $-55
2014 $-129
2013 $-63
2012 $-27
2011 $-19
2010 $-9
2009 $-22
OPKO Health Quarterly EBITDA
(Millions of US $)
2024-09-30 $39
2024-06-30 $-37
2024-03-31 $-45
2023-12-31 $-43
2023-09-30 $-38
2023-06-30 $34
2023-03-31 $-4
2022-12-31 $-29
2022-09-30 $-61
2022-06-30 $18
2022-03-31 $-44
2021-12-31 $-44
2021-09-30 $57
2021-06-30 $26
2021-03-31 $59
2020-12-31 $70
2020-09-30 $43
2020-06-30 $50
2020-03-31 $-19
2019-12-31 $-89
2019-09-30 $-15
2019-06-30 $-24
2019-03-31 $-51
2018-12-31 $-66
2018-09-30 $-9
2018-06-30 $20
2018-03-31 $-18
2017-12-31 $-132
2017-09-30 $-22
2017-06-30 $-0
2017-03-31 $-19
2016-12-31 $-50
2016-09-30 $2
2016-06-30 $53
2016-03-31 $-5
2015-12-31 $14
2015-09-30 $4
2015-06-30 $-21
2015-03-31 $-53
2014-12-31 $-29
2014-09-30 $-44
2014-06-30 $-29
2014-03-31 $-27
2013-12-31 $-31
2013-09-30 $-15
2013-06-30 $-14
2013-03-31 $-3
2012-12-31 $-7
2012-09-30 $-7
2012-06-30 $-7
2012-03-31 $-7
2011-12-31 $-8
2011-09-30 $-5
2011-06-30 $-4
2011-03-31 $-3
2010-12-31 $3
2010-09-30 $-4
2010-06-30 $-5
2010-03-31 $-3
2009-12-31 $-3
2009-09-30 $-5
2009-06-30 $-5
2009-03-31 $-8
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.065B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $204.963B 25.00
Intuitive Surgical (ISRG) United States $191.657B 100.20
Edwards Lifesciences (EW) United States $43.285B 27.49
Alcon (ALC) Switzerland $42.325B 28.32
IQVIA Holdings (IQV) United States $36.881B 20.32
IDEXX Laboratories (IDXX) United States $36.416B 42.88
DexCom (DXCM) United States $31.017B 46.71
Waters (WAT) United States $23.177B 34.27
STERIS (STE) Ireland $21.145B 24.34
SONOVA HOLDING (SONVY) Switzerland $19.889B 0.00
Hologic (HOLX) United States $17.436B 18.83
Fresenius Medical Care AG KGaA (FMS) Germany $14.025B 14.40
Sysmex ADR (SSMXY) Japan $12.739B 39.95
Globus Medical (GMED) United States $11.287B 28.58
Masimo (MASI) United States $9.351B 45.25
Penumbra (PEN) United States $9.298B 91.08
Teleflex (TFX) United States $8.663B 13.82
Glaukos (GKOS) United States $7.520B 0.00
PROCEPT BioRobotics (PRCT) United States $4.758B 0.00
Integer Holdings (ITGR) United States $4.684B 26.55
Veracyte (VCYT) United States $3.331B 99.95
Inari Medical (NARI) United States $3.223B 0.00
LivaNova (LIVN) United Kingdom $2.717B 15.69
Nihon Kohden (NHNKY) Japan $2.514B 19.10
TransMedics (TMDX) United States $2.315B 73.39
Elekta AB (EKTAY) Sweden $2.239B 20.13
Tandem Diabetes Care (TNDM) United States $2.221B 0.00
Integra LifeSciences Holdings (IART) United States $1.853B 9.68
RxSight (RXST) United States $1.579B 0.00
Alphatec Holdings (ATEC) United States $1.369B 0.00
Artivion (AORT) United States $1.250B 82.86
Pulse Biosciences (PLSE) United States $1.025B 0.00
Paragon 28 (FNA) United States $0.879B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.859B 14.60
ORTHOFIX MEDICAL INC (OFIX) United States $0.709B 0.00
IRadimed (IRMD) United States $0.701B 37.88
Mesa Laboratories (MLAB) United States $0.700B 16.50
AxoGen (AXGN) United States $0.653B 0.00
Pacific Biosciences Of California (PACB) United States $0.641B 0.00
SiBone (SIBN) United States $0.596B 0.00
OrthoPediatrics (KIDS) United States $0.556B 0.00
Semler Scientific (SMLR) United States $0.496B 29.18
Treace Medical Concepts (TMCI) United States $0.492B 0.00
ClearPoint Neuro (CLPT) United States $0.460B 0.00
Tactile Systems Technology (TCMD) United States $0.449B 24.29
Delcath Systems (DCTH) United States $0.373B 0.00
AngioDynamics (ANGO) United States $0.361B 0.00
NeuroPace (NPCE) United States $0.344B 0.00
CVRx (CVRX) United States $0.330B 0.00
Inogen (INGN) United States $0.231B 0.00
Alpha Tau Medical (DRTS) Israel $0.212B 0.00
Accuray (ARAY) United States $0.208B 0.00
Sight Sciences (SGHT) United States $0.198B 0.00
KORU Medical Systems (KRMD) United States $0.180B 0.00
Nevro (NVRO) United States $0.163B 0.00
Atossa Genetics (ATOS) United States $0.159B 0.00
Sensus Healthcare (SRTS) United States $0.145B 15.56
Spectral Diagnostics (EDTXF) Canada $0.106B 0.00
WORK Medical Technology Group (WOK) China $0.093B 0.00
Monogram Orthopaedics (MGRM) United States $0.092B 0.00
Vicarious Surgical (RBOT) United States $0.091B 0.00
LENSAR (LNSR) United States $0.088B 0.00
EDAP TMS S.A (EDAP) France $0.085B 0.00
908 Devices (MASS) United States $0.084B 0.00
InspireMD (NSPR) Israel $0.082B 0.00
Hyperfine (HYPR) United States $0.072B 0.00
Covalon Technologies (CVALF) Canada $0.070B 0.00
EnVVeno Medical (NVNO) United States $0.052B 0.00
Lucid Diagnostics (LUCD) United States $0.047B 0.00
Rapid Micro Biosystems (RPID) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.043B 0.00
Spectral AI (MDAI) United States $0.038B 0.00
Accelerate Diagnostics (AXDX) United States $0.036B 0.00
Adagio Medical Holdings (ADGM) United States $0.035B 0.00
Neuronetics (STIM) United States $0.035B 0.00
Precision Optics (POCI) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.024B 0.00
NexGel (NXGL) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.022B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
Baird Medical Investment Holdings (BDMD) $0.012B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
PAVmed (PAVM) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00